Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Bio-Rad Denmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.3% 1.3%   Bankruptcy risk   2.4% 2.3% 2.5% 1.7% 1.2% 0.6% 5.3% 5.0%   Credit score (0-100)   65 66 62 72 82 96 42 44   Credit rating   BBB BBB BBB A A AA BBB BBB   Credit limit (kDKK)   0.0 0.1 0.0 10.7 324.1 1,044.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,535 10,501 14,052 13,683 18,200 12,909 0.0 0.0   EBITDA   2,271 2,897 3,387 3,612 4,523 2,591 0.0 0.0   EBIT   936 1,223 2,043 2,203 2,753 590 0.0 0.0   Pre-tax profit (PTP)   920.0 1,179.0 2,036.6 2,142.7 2,788.3 1,153.0 0.0 0.0   Net earnings   706.0 826.0 1,659.0 1,644.6 2,185.3 910.2 0.0 0.0   Pre-tax profit without non-rec. items   920 1,179 2,037 2,143 2,788 1,153 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   759 614 391 197 1,694 1,438 0.0 0.0   Shareholders equity total   756 1,581 3,240 4,885 7,070 7,980 7,930 7,930   Interest-bearing liabilities   15,821 8,311 27,156 21,811 1,614 7,826 0.0 0.0   Balance sheet total (assets)   21,014 14,796 40,571 35,411 21,651 22,037 7,930 7,930   Net Debt   15,821 8,311 27,156 21,811 1,614 7,826 -6,838 -6,838     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,535 10,501 14,052 13,683 18,200 12,909 0.0 0.0   Gross profit growth   0.0% 89.7% 33.8% -2.6% 33.0% -29.1% -100.0% 0.0%   Employees   8 9 10 10 10 9 0 0   Employee growth %   0.0% 12.5% 11.1% 0.0% 0.0% -10.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   21,014 14,796 40,571 35,411 21,651 22,037 7,930 7,930   Balance sheet change%   0.0% -29.6% 174.2% -12.7% -38.9% 1.8% -64.0% 0.0%   Added value   2,271.0 2,897.0 3,387.0 3,611.9 4,161.8 2,590.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   5,962 -2,909 -2,655 -2,692 -1,362 -3,346 -1,438 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.9% 11.6% 14.5% 16.1% 15.1% 4.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.5% 6.9% 7.4% 5.8% 9.9% 5.4% 0.0% 0.0%   ROI %   5.5% 9.0% 10.0% 7.7% 15.8% 9.5% 0.0% 0.0%   ROE %   93.4% 70.7% 68.8% 40.5% 36.6% 12.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   3.7% 11.1% 8.2% 13.8% 32.7% 36.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   696.7% 286.9% 801.8% 603.9% 35.7% 302.1% 0.0% 0.0%   Gearing %   2,092.7% 525.7% 838.1% 446.5% 22.8% 98.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.2% 0.4% 0.0% 0.2% 0.3% 0.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.7 1.0 1.0 1.2 1.4 0.0 0.0   Current Ratio   0.7 0.7 1.0 1.1 1.2 1.4 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -6,174.0 -4,003.0 -1,204.0 1,626.7 3,419.3 5,633.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   284 322 339 361 416 288 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   284 322 339 361 452 288 0 0   EBIT / employee   117 136 204 220 275 66 0 0   Net earnings / employee   88 92 166 164 219 101 0 0